GHK-CU 100mg

Documentation: Batch-specific Certificates of Analysis (COAs) are included within the product image gallery for reference.

FOR RESEARCH USE ONLY 

Intended Use: This product is supplied strictly for laboratory research use only. Not for human or veterinary use.

GHK-Cu (Copper Tripeptide-1), 100 mg is a synthetic complex consisting of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine (GHK) bound to a copper (II) ion. Endogenous GHK-Cu has been identified in human plasma and tissues and is involved in normal biological processes related to cellular signalling and extracellular matrix regulation.

GHK-Cu has been investigated primarily in non-clinical and preclinical research settings, as well as in limited cosmetic and laboratory contexts, to study its interaction with cellular pathways associated with tissue maintenance and repair. At present, GHK-Cu is not included on the Australian Register of Therapeutic Goods (ARTG) and is not approved by the Therapeutic Goods Administration (TGA) for the prevention, diagnosis, treatment, or cure of any disease or medical condition.

Technical Specifications - GHK-CU 100 mg

• Name: GHK-Cu (Copper Tripeptide-1)
• Peptide Sequence: Gly-His-Lys
  (GHK tripeptide chelated with Cu²⁺ to form the copper complex)
• Molecular Weight:
  • GHK peptide: ~340.38 Da
  • GHK-Cu complex: ~403–405 Da (varies slightly depending on hydration state)
• Molecular Formula:
  • GHK: C₁₄H₂₂N₆O₄
  • GHK-Cu complex: C₁₄H₂₂CuN₆O₄
• CAS Number: 49557-75-7
• Quantity: 100 mg (lyophilized powder)
• Physical Form: Lyophilized (freeze-dried) blue to blue-green powder (color results from copper complex)
• Purity: Research-grade, typically ≥ 98–99% purity verified by HPLC
• Solubility:
  • Soluble in sterile water for in-vitro laboratory use
  • Stable in mild aqueous buffers (pH ~5–7 ideal for copper complex integrity)
  • Avoid strong acids, high pH, or chelating agents (e.g., EDTA) as these may disrupt the copper–peptide bond
  • Mix gently—do not vortex aggressively
• Storage / Handling:
  • Before reconstitution: Store at –20 °C or colder, protected from moisture and light
  • After reconstitution: Store at 2–8 °C; use shortly after reconstitution
  • Minimize freeze–thaw cycles
  • Allow vial to reach room temperature before opening to reduce condensation exposure
• Intended Application:
  Labeled Research Use Only (RUO). Suitable for biochemical, cell signaling, gene expression, and peptide–metal binding studies in controlled laboratory environments.
  Not intended for human or veterinary therapeutic or cosmetic use.
• General Notes:
  GHK-Cu is a naturally occurring copper-binding peptide studied in laboratory models for its biochemical interactions related to oxidative stress, tissue repair pathways, and cellular signaling. Any biological activity referenced in literature applies to experimental research conditions only. Long-term safety and efficacy in humans have not been established.

Product Disclaimer

This product is supplied for laboratory research use only. It has not been approved by any national regulatory authority (including the FDA, EMA, or Australian TGA) for human therapeutic, diagnostic, or veterinary use. The purchaser assumes full responsibility for the handling, storage, and disposal of this material in accordance with all applicable institutional, local, and national regulations.

The manufacturer/distributor makes no claims regarding the safety, efficacy, or suitability of this material for any medical or cosmetic application, nor for human or animal administration. This product should not be ingested, injected, applied topically, or otherwise administered to humans or animals except within an approved clinical or laboratory protocol using appropriate GMP-grade material.

This product must be handled only by qualified laboratory personnel trained in safe handling of reagents and peptides. Keep out of reach of children. The product is supplied “as is”, without warranty, express or implied, including any guarantee of fitness for a particular purpose. Users should consult safety documentation and institutional biosafety officers before use.